Diabetes Insights - Breakthroughs and Innovators

In this episode, Professors Hood Thabit (University of Manchester, UK) and Helen Murphy (University of East Anglia, Norwich, UK) join Vivienne Parry and EASD to discuss the opportunities and persistent challenges in diabetes care in hospitals and pregnancy.

The conversation examines how diabetes technology - from continuous glucose monitoring (CGM) to hybrid closed-loop systems - is improving outcomes for people with diabetes in inpatient settings and for pregnant women with type 1 diabetes. The guests reflect on recent advances, national implementation success stories from the NHS, and gaps that still exist in gestational and type 2 diabetes care.

A compelling...

In this episode, we explore the fascinating history, fall, and resurgence of GIP (glucose-dependent insulinotropic polypeptide) in diabetes therapy. Once overshadowed by GLP-1, GIP is now back in the spotlight, thanks to dual and triple agonist therapies like tirzepatide. Experts discuss how GIP signaling in the brain may influence appetite and weight regulation, why early studies underestimated its therapeutic value, and what the future holds for multi-agonist drug development in metabolic disease.
Join Prof. Michael Nauck from the University of Bochum, Dr. Alice Adriaenssens from UCL and our host, Vivienne Perry as they revisit the incretin story, unpack recent breakthroughs...

In this episode, we explore the evolving world of cell therapy in type 1 diabetes. Professor James Shaw (Newcastle University), Dr Timothy Kieffer (University of British Columbia & Fractal Health), and Dr Trevor Reichman (University of Toronto) join EASD to discuss the established role of islet transplants and the exciting promise of stem cell–derived islets.

The conversation covers the clinical realities of pancreas and islet cell transplants, the challenges of immunosuppression, and how scalable, gene-edited stem cell therapies could shape the future of diabetes care.

From early trial successes to the potential of immune-evasive cells and gene therapies for GLP-1...

Today’s episode is special, as the topic was requested by members of the Early Career Academy. The spotlight is on work-life balance in academic medicine and research.

Dr Anna Krook from the Karolinska Institute in Sweden and Dr Benoit Gauthier from the Andalusian Molecular Biology and Regenerative Medicine Centre – CABIMER with the Ministry of Health of Andalusia in Spain, delve into the critical topic of work-life balance for everyone but specifically, early career academics.

Listen in as they discuss the unique challenges faced during this demanding period, including securing grants, managing teaching responsibilities, and navigating personal relationships. The conversation...